E1	Procedure:T1 
E2	Negation:T2 Negates:E1
E4	Drug:T4 Name:T53 Temporality:E33
E6	Drug:T6 Name:T33
E8	Drug:T8 Name:T34 Temporality:E33
E9	Drug:T9 Name:T35
E11	Drug:T11 Name:T36 Temporality:E33
E12	Drug:T12 Name:T37
E13	Condition:T13 Name:T38
E18	Modifier:T18 Modifies:T44
E19	Condition:T19 Name:T44
E20	Eq-Comparison:T20 Temporal-Period:T45
E21	Procedure:T21 Name:T46 Temporality:E20
E22	Drug:T22 Name:T47
E24	Drug:T24 Name:T48
E25	Eq-Comparison:T25 Operator:T50 Value:T51 Temporal-Unit:T52
E27	Procedure:T27 Temporality:E28
E28	Eq-Comparison:T28 Temporal-Recency:T49
E30	Study:T30 
E31	Negation:T31 Negates:E42
E32	Procedure:T32 Name:T59
E33	Eq-Comparison:T54 Temporal-Period:T55
E35	Negation:T57 Negates:E19
E14	Modifier:T14 Modifies:T38
E15	Modifier:T15 Modifies:T38
E36	Modifier:T39 Modifies:T38
E37	Modifier:T40 Modifies:T38
E38	Modifier:T41 Modifies:T38
E39	Modifier:T42 Modifies:T38
E40	Modifier:T43 Modifies:T38
E42	Study:T60 Study-Of:E32
T1	Procedure 25 34	Treatment
T2	Negation 35 40	na√Øve
T4	Drug 46 52	pegIFN
T6	Drug 57 60	IFN
T8	Drug 70 79	Ribavirin
T9	Drug 81 84	RBV
T11	Drug 93 103	sofosbuvir
T12	Drug 105 108	PRS
T13	Condition 137 140	CHC
T18	Modifier 189 200	compensated
T19	Condition 201 210	cirrhosis
T20	Eq-Comparison 212 221	receiving
T21	Procedure 222 241	combination therapy
T22	Drug 255 263	oral GLE
T24	Drug 264 267	PIB
T25	Eq-Comparison 395 408	up to 4 weeks
T27	Procedure 415 424	treatment
T28	Eq-Comparison 425 435	initiation
T30	Study 532 537	study
T31	Negation 557 560	not
T32	Procedure 637 648	therapeutic
T33	Drug-Name 57 60	IFN
T34	Drug-Name 70 79	Ribavirin
T35	Drug-Name 81 84	RBV
T36	Drug-Name 93 103	sofosbuvir
T37	Drug-Name 105 108	PRS
T38	Condition-Name 137 140	CHC
T44	Condition-Name 201 210	cirrhosis
T45	Eq-Temporal-Period 212 221	receiving
T46	Procedure-Name 222 241	combination therapy
T47	Drug-Name 255 263	oral GLE
T48	Drug-Name 264 267	PIB
T50	Eq-Operator 395 400	up to
T51	Eq-Value 401 402	4
T52	Eq-Temporal-Unit 403 408	weeks
T53	Drug-Name 46 52	pegIFN
T54	Eq-Comparison 110 121	experienced
T55	Eq-Temporal-Period 110 121	experienced
T57	Negation 181 188	without
T14	Modifier 142 151	genotypes
T15	Modifier 152 153	1
T39	Modifier 155 156	2
T40	Modifier 158 159	3
T41	Modifier 161 162	4
T42	Modifier 164 165	5
T43	Modifier 170 171	6
T49	Eq-Temporal-Recency 425 435	initiation
T59	Procedure-Name 637 648	therapeutic
T60	Study 649 654	trial
A3	Eq-Temporal-Period-Value T45 present
A5	Eq-Operator-Value T50 LTEQ
A6	Eq-Temporal-Unit-Value T52 week
A7	Eq-Temporal-Period-Value T55 past
A4	Eq-Temporal-Recency-Value T49 first-time
R1	Abbrev-Of Arg1:E9 Arg2:E8
R2	Abbrev-Of Arg1:E12 Arg2:E11
R3	Using Arg1:E21 Arg2:E22
R4	Using Arg1:E21 Arg2:E24
R5	Or Arg1:E2 Arg2:E4
R6	Or Arg1:E4 Arg2:E6
R7	Or Arg1:E4 Arg2:E8
R8	Or Arg1:E8 Arg2:E11
R10	Or Arg1:E22 Arg2:E24
R11	After Arg1:E25 Arg2:E28
R12	And Arg1:E12 Arg2:E13
R13	Or Arg1:E39 Arg2:E40
R9	Or Arg1:E15 Arg2:E36
R14	Or Arg1:E36 Arg2:E37
R15	Or Arg1:E37 Arg2:E38
R16	Or Arg1:E38 Arg2:E39
